Measles Resource Center

Measles is a highly contagious viral infection that spreads through droplet and airborne routes, such as the air when an infected person coughs or sneezes. This disease typically presents as flu-like symptoms (prodrome) between 7-14 days after contact, followed by rash on the face or neck that spreads downward to the rest of the body. There is no specific antiviral therapy for measles and therefore treatment consists of supportive care for symptomatic relief and prevention of severe complications such as encephalitis or even death.

The American Academy of Pediatrics (AAP) and Centers for Disease Control and Prevention (CDC) recommend routine vaccination against measles. Two doses of measles, mumps, and rubella (MMR) are 97% effective in preventing infection. Below summarizes MMR vaccine recommendations from the CDC:

• Children 12 months through 12 years: 2 doses - 1st at 12-15 months, 2nd at 4-6 years (can administer 2nd dose early if needed, at least 28 days apart)
• Individuals 13 years and older: 1-2 doses, unless there is evidence of immunity
• Pregnant or severely immunocompromised individuals: contraindicated, use immunoglobulin for post-exposure prophylaxis if exposed

The CDC recommends post-exposure prophylaxis for individuals without prior adequate measles immunity using MMR vaccination if within 72 hours of exposure, or immunoglobulin if within 6 days of exposure. MMR and immunoglobulin should not be administered simultaneously as concomitant use will invalidate the vaccine.

How Can Pharmacists and Pharmacy Technicians Help?

• Vaccinate
• Educate
• Identify Symptoms